We present here a pilot study that aimed to address these issues, evaluating both the complete serum NSs’ profile and clinical characteristics of a cohort of consecutive GBA-PD patients compared to a matched cohort of consecutive NM-PD patients and two cohorts of healthy subjects with (GBA-HC) and without (NM-HC) GBA mutations. The gene discussed is GBA1; the disease is Parkinson disease.